Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
DOI:
https://doi.org/10.2340/actadv.v102.1962Keywords:
Psoriasis, psoriatic arthritis, incidence, prevalence, mortality, epidemiologyAbstract
There is a recognized need to better understand changes in the epidemiology of psoriasis and psoriatic arthritis (PsA) over time in Asia. Using the Taiwan National Health Insurance claim records this population-based study examined changes in the prevalence, incidence, and mortality rates in patients with psoriasis or psoriatic arthritis in Taiwan over 12 years. Patients with ≥1 diagnosis code for psoriasis or psoriatic arthritis, recorded either by dermatologists or rheumatologists, were identified. Annual age- and sex-standardized prevalence and incidence rates were calculated using the Taiwan general population as reference. To investigate mortality, each patient in the incident cohort was matched to 10 comparators from the general population by sex and age (at diagnosis). The risk of mortality between study cohorts and comparators was analysed by Cox proportional hazard regression. The prevalence of psoriasis (0.18–0.86%) and psoriatic arthritis (0.01–0.08%) increased steadily between 2006 and 2017. The incidence rates, however, remained stable (psoriasis: 62–65 per 100,000 person-years; psoriatic arthritis: 6–5 per 100,000 person-years). The risk of all-cause mortality for patients with psoriasis (hazard ratio 1.16; 95% confidence interval: 1.13–1.19) was higher than the general population, despite a decreasing trend over time in the all-cause mortality rates for both groups. The steady increase in the prevalence of psoriasis despite stable incidence rates suggests that improvements in life expectancy may be the key determinant of this increase.
Downloads
References
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet 2021; 397: 1301-1315.
https://doi.org/10.1016/S0140-6736(20)32549-6 DOI: https://doi.org/10.1016/S0140-6736(20)32549-6
Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271.
https://doi.org/10.1016/S0140-6736(07)61128-3 DOI: https://doi.org/10.1016/S0140-6736(07)61128-3
Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a UK population-based cohort study. Br J Dermatol 2017; 176: 650-658.
https://doi.org/10.1111/bjd.15021 DOI: https://doi.org/10.1111/bjd.15021
World Health Organization (WHO). Global report on psoriasis. Geneva: WHO, 2016.
Hsieh C-Y, Su C-C, Shao S-C, Sung S-F, Lin S-J, Yang Y-HK, et al. Taiwan's National Health Insurance Research Database: past and future. Clin Epidemiol 2019; 11 349-358.
https://doi.org/10.2147/CLEP.S196293 DOI: https://doi.org/10.2147/CLEP.S196293
Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol 2020; 184: 243-258.
https://doi.org/10.1111/bjd.19169 DOI: https://doi.org/10.1111/bjd.19169
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 2020; 369: m1590.
https://doi.org/10.1136/bmj.m1590 DOI: https://doi.org/10.1136/bmj.m1590
Chang Y-T, Chen T-J, Liu P-C, Chen Y-C, Chen Y-J, Huang Y-L, et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 2009; 89: 262-266.
https://doi.org/10.2340/00015555-0642 DOI: https://doi.org/10.2340/00015555-0642
Tsai TF, Wang TS, Hung ST, Tsai PIC, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 2011; 63: 40-46.
https://doi.org/10.1016/j.jdermsci.2011.03.002 DOI: https://doi.org/10.1016/j.jdermsci.2011.03.002
Wang TS, Hsieh CF, Tsai TF. Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: a nationwide, population-based observational study in Taiwan. J Dermatol Sci 2016; 84: 340-345.
https://doi.org/10.1016/j.jdermsci.2016.08.535 DOI: https://doi.org/10.1016/j.jdermsci.2016.08.535
Wei JCC, Shi LH, Huang JY, Wu XF, Wu R, Chiou JY. Epidemiology and medication pattern change of psoriatic diseases in Taiwan from 2000 to 2013: a nationwide, population-based cohort study. J Rheumatol 2018; 45: 385-392.
https://doi.org/10.3899/jrheum.170516 DOI: https://doi.org/10.3899/jrheum.170516
Lee MS, Yeh YC, Chang YT, Lai MS. All-cause and cause-specific mortality in patients with psoriasis in Taiwan: a nationwide population-based study. J Invest Dermatol 2017 137: 1468-1473.
https://doi.org/10.1016/j.jid.2017.01.036 DOI: https://doi.org/10.1016/j.jid.2017.01.036
World Health Organization (WHO). 67th World Health Assembly: psoriasis. WHA67.9. Geneva: WHO. 2014.
Tripepi G, Jager KJ, Dekker FW, Zoccali C. Stratification for confounding - part 2: direct and indirect standardization. Nephron Clin Pract 2010; 116: c322-c325.
https://doi.org/10.1159/000319591 DOI: https://doi.org/10.1159/000319591
Department of Household Registration Ministry of the Interior Republic of China (Taiwan). Population by sex and 5 year age group for counties and cities.xls. [accessed 2020, March 15] Available at: https://www.ris.gov.tw/app/en/3910.
Han JH, Lee JH, Han KD, Seo HM, Bang CH, Park YM, et al. Epidemiology and medication trends in patients with psoriasis: a nationwide population-based cohort study from Korea. Acta Derm Venereol 2018; 98: 396-400.
https://doi.org/10.2340/00015555-2877 DOI: https://doi.org/10.2340/00015555-2877
Lee JY, Kang S, Park JS, Jo SJ. Prevalence of psoriasis in Korea: a population-based epidemiological study using the Korean National Health Insurance Database. Ann Dermatol 2017; 29: 761-767.
https://doi.org/10.5021/ad.2017.29.6.761 DOI: https://doi.org/10.5021/ad.2017.29.6.761
Sewerin P, Brinks R, Schneider M, Haase I, Vordenbaumen S. Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis 2019; 78: 286-287.
https://doi.org/10.1136/annrheumdis-2018-214065 DOI: https://doi.org/10.1136/annrheumdis-2018-214065
Tollefson MM, Crowson CS, McEvoy MT, Kremers HM. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol 2010; 62: 979-987.
https://doi.org/10.1016/j.jaad.2009.07.029 DOI: https://doi.org/10.1016/j.jaad.2009.07.029
Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394-401.
https://doi.org/10.1016/j.jaad.2008.10.062 DOI: https://doi.org/10.1016/j.jaad.2008.10.062
Henan Dermatoses Survey Group. An analysis of 487 cases of psoriasis in 100,000 natural population of Henan rural district. Chin J Dermatol 1982; 15: 83-84.
Changgeng S, Guowei Z, Guangchao W. Distribution of psoriasis in China: a nationwide screening. Proc Chin Acad Med Sci Peking Union Med Coll 1987; 2: 59-65.
Ding XL, Wang TL, Shen YW, Wang XY, Zhou C, Tian S, et al. Prevalence of psoriasis in China: a population-based study in six cities. Eur J Dermatol 2012; 22: 663-667.
https://doi.org/10.1684/ejd.2012.1802 DOI: https://doi.org/10.1684/ejd.2012.1802
Li Meijiao, Wang Peng, Cai Min, Liu Qiao, Wu Weiwei, Fu Lei, et al. Prevalence and risk factors of psoriasis in Hainan province: an epidemiological survey. Chin J Dermatol 2013; 46: 157-159.
Ministry of Health and Welfare. 107 Annual National Health Insurance Medical Statistics Annual Report. [accessed 2020, May 18] Available at: https://dep.mohw.gov.tw/DOS/lp-4648-113.html.
Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 2013; 52: 568-575.
https://doi.org/10.1093/rheumatology/kes324 DOI: https://doi.org/10.1093/rheumatology/kes324
Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456.
https://doi.org/10.1016/S0190-9622(85)70188-0 DOI: https://doi.org/10.1016/S0190-9622(85)70188-0
Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F, et al. Age at onset and different types of psoriasis. Br J Dermatol 1995; 133: 768-773.
https://doi.org/10.1111/j.1365-2133.1995.tb02753.x DOI: https://doi.org/10.1111/j.1365-2133.1995.tb02753.x
Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002 46: 867-873.
https://doi.org/10.1067/mjd.2002.120470 DOI: https://doi.org/10.1067/mjd.2002.120470
Farber EM, Nall L. The natural history of psoriasis in 5,600 patients. Dermatology 1974; 148: 1-18.
https://doi.org/10.1159/000251595 DOI: https://doi.org/10.1159/000251595
Youn JI, Park B-S, Park S-B, Kim S-D, Suh D-H. Characterization of early and late onset psoriasis in the Korean population. J Dermatol 1999; 26: 647-652.
https://doi.org/10.1111/j.1346-8138.1999.tb02066.x DOI: https://doi.org/10.1111/j.1346-8138.1999.tb02066.x
Chularojanamontri L, Kulthanan K, Suthipinittharm P, Jiamton S, Wongpraparut C, Silpa-Archa N, et al. Clinical differences between early- and late-onset psoriasis in Thai patients. Int J Dermatol 2015; 54: 290-294.
https://doi.org/10.1111/ijd.12515 DOI: https://doi.org/10.1111/ijd.12515
Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-537.
https://doi.org/10.1111/j.1365-2133.1996.tb03826.x DOI: https://doi.org/10.1111/j.1365-2133.1996.tb03826.x
Schonmann Y, Ashcroft DM, Iskandar IYK, Parisi R, Sde-Or S, Comaneshter D et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. J Eur Acad Dermatol Venereol 2019; 33: 2075-2081.
https://doi.org/10.1111/jdv.15762 DOI: https://doi.org/10.1111/jdv.15762
Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and prevalence of psoriasis in Denmark. Acta Derm Venereol 2017; 97: 808-812.
https://doi.org/10.2340/00015555-2672 DOI: https://doi.org/10.2340/00015555-2672
Chiu HY, Huang PY, Jee SH, Hu CY, Chou CT, Chang YT, et al. HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis. Br J Dermatol 2011; 166: 288-297.
https://doi.org/10.1111/j.1365-2133.2011.10688.x DOI: https://doi.org/10.1111/j.1365-2133.2011.10688.x
Chen L, Tsai TF. HLA-Cw6 and psoriasis. Br J Dermatol 2018; 178: 854-862.
https://doi.org/10.1111/bjd.16083 DOI: https://doi.org/10.1111/bjd.16083
Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, et al. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br J Dermatol 2003; 148: 418-423.
https://doi.org/10.1046/j.1365-2133.2003.05166.x DOI: https://doi.org/10.1046/j.1365-2133.2003.05166.x
Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-1499.
https://doi.org/10.1001/archderm.143.12.1493 DOI: https://doi.org/10.1001/archderm.143.12.1493
Salahadeen E, Torp-Pedersen C, Gislason G, Hansen PR, Ahlehoff O. Nationwide population-based study of cause-specific death rates in patients with psoriasis. J Eur Acad Dermatol Venereol 2015; 29: 1002-1005.
https://doi.org/10.1111/jdv.12523 DOI: https://doi.org/10.1111/jdv.12523
Svedbom A, Dalén J, Mamolo C, Cappelleri JC, Mallbris L, Petersson IF, et al. Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study. Acta Derm Venereol 2015; 95: 809-815.
https://doi.org/10.2340/00015555-2095 DOI: https://doi.org/10.2340/00015555-2095
Ryan C, Kirby B. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatol Clin 2015; 33: 41-55.
https://doi.org/10.1016/j.det.2014.09.004 DOI: https://doi.org/10.1016/j.det.2014.09.004
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
https://doi.org/10.1007/s00403-006-0703-z DOI: https://doi.org/10.1007/s00403-006-0703-z
Onumah N, Kircik LH. Psoriasis and its comorbidities. J Drugs Dermatol 2012; 11: s5-s10.
Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ. Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 2014; 170: 304-314.
https://doi.org/10.1111/bjd.12670 DOI: https://doi.org/10.1111/bjd.12670
Brenaut E, Horreau C, Pouplard C, Barnetche T, Paul C, Richard MA, et al. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2013; 27: 30-35.
https://doi.org/10.1111/jdv.12164 DOI: https://doi.org/10.1111/jdv.12164
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Ireny Y.K. Iskandar, Teng-Chou Chen, Li-Chia Chen, Meng-Sui Lee, Yen-Yun Yang, Ting-Chun Wang, Yu-Chun Hsieh, K. Arnold Chan, Christopher E.M. Griffiths, Darren M. Ashcroft
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
